MX2013004062A - Analogos de ciclosporina. - Google Patents

Analogos de ciclosporina.

Info

Publication number
MX2013004062A
MX2013004062A MX2013004062A MX2013004062A MX2013004062A MX 2013004062 A MX2013004062 A MX 2013004062A MX 2013004062 A MX2013004062 A MX 2013004062A MX 2013004062 A MX2013004062 A MX 2013004062A MX 2013004062 A MX2013004062 A MX 2013004062A
Authority
MX
Mexico
Prior art keywords
cyclosporin analogs
cyclosporin
analogs
treatment
disclosed
Prior art date
Application number
MX2013004062A
Other languages
English (en)
Inventor
William Robert Carling
Michael E Garst
Michael E Stern
Christopher S Schaumburg
David Arthur Scowen
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2013004062A publication Critical patent/MX2013004062A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Abstract

Se describen en la presente nuevos análogos de ciclosporina, composiciones farmacéuticas que los contienen, y métodos para su uso en el tratamiento del ojo seco y otras afecciones.
MX2013004062A 2010-10-12 2011-10-11 Analogos de ciclosporina. MX2013004062A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39245110P 2010-10-12 2010-10-12
PCT/US2011/055788 WO2012051193A1 (en) 2010-10-12 2011-10-11 Cyclosporin analogs

Publications (1)

Publication Number Publication Date
MX2013004062A true MX2013004062A (es) 2013-07-22

Family

ID=44883796

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004062A MX2013004062A (es) 2010-10-12 2011-10-11 Analogos de ciclosporina.

Country Status (12)

Country Link
US (2) US9175042B2 (es)
EP (1) EP2627663B1 (es)
JP (1) JP5805773B2 (es)
KR (1) KR20140026328A (es)
CN (1) CN103261212A (es)
AU (1) AU2011316689B2 (es)
BR (1) BR112013008749A2 (es)
CA (1) CA2814191A1 (es)
IL (1) IL225616A0 (es)
MX (1) MX2013004062A (es)
RU (1) RU2013120927A (es)
WO (1) WO2012051193A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010138422A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
WO2012079172A1 (en) * 2010-12-15 2012-06-21 Isotechnika Pharma Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
AU2013267435B2 (en) * 2012-06-01 2017-11-09 Allergan, Inc. Cyclosporin A analogs
WO2014138437A1 (en) 2013-03-08 2014-09-12 Allergan, Inc. Steroid conjugates
US9914755B2 (en) 2015-01-08 2018-03-13 Allergan, Inc. Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
US10610104B2 (en) 2016-12-07 2020-04-07 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
EP3554346B1 (en) 2016-12-14 2024-01-31 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with an immunosuppressant
US20230041197A1 (en) 2018-06-20 2023-02-09 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
CN115028681B (zh) * 2022-08-11 2022-11-15 中国科学院微生物研究所 一种降解亲环素a的嵌合体化合物及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US5474979A (en) 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2762843B1 (fr) 1997-04-30 1999-12-10 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2772768B1 (fr) * 1997-12-19 2000-01-14 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine
KR20010052766A (ko) 1998-06-12 2001-06-25 침머만 다니엘 신규한 사이클로스포린
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
CN100478025C (zh) * 2005-03-25 2009-04-15 中国科学院上海药物研究所 一种环孢菌素a眼用微乳制剂及其制备方法
JP5377293B2 (ja) * 2006-05-19 2013-12-25 スシネキス インク 眼疾患の治療及び予防方法
US20100144609A1 (en) * 2007-05-04 2010-06-10 Donnenfeld Eric D Methods using cyclosporin in treating patients with intraocular lenses
WO2010006117A2 (en) 2008-07-10 2010-01-14 Allergan, Inc. Cyclosporin derivatives for treating ocular and dermal diseases and conditions
WO2012009715A2 (en) 2010-07-16 2012-01-19 S&T Global Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
US9573978B2 (en) * 2010-08-12 2017-02-21 S&T Global, Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
JP5805774B2 (ja) 2010-10-12 2015-11-10 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ シクロスポリンアナログ
MX350746B (es) * 2010-12-03 2017-09-14 Hebei Kunxiangjishi Pharmaceutical Tech Co Ltd Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral.
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof

Also Published As

Publication number Publication date
EP2627663A1 (en) 2013-08-21
IL225616A0 (en) 2013-06-27
US20120135939A1 (en) 2012-05-31
US9175042B2 (en) 2015-11-03
WO2012051193A1 (en) 2012-04-19
US9561259B2 (en) 2017-02-07
KR20140026328A (ko) 2014-03-05
US20160022765A1 (en) 2016-01-28
BR112013008749A2 (pt) 2019-09-24
AU2011316689B2 (en) 2016-07-14
AU2011316689A1 (en) 2013-05-02
CA2814191A1 (en) 2012-04-19
JP2013544786A (ja) 2013-12-19
JP5805773B2 (ja) 2015-11-10
RU2013120927A (ru) 2014-11-20
CN103261212A (zh) 2013-08-21
EP2627663B1 (en) 2018-02-21

Similar Documents

Publication Publication Date Title
MX2013004061A (es) Analogos de ciclosporina.
MX2013004062A (es) Analogos de ciclosporina.
TN2015000278A1 (en) Autotaxin inhibitors
IN2015DN01156A (es)
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
GB201106750D0 (en) Novel compounds
MX2013006040A (es) Antagonistas del receptor de acido lisofosfatidico y su uso en el tratamiento de fibrosis.
TN2012000414A1 (en) Forms of rifaximin and uses thereof
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
GB201106743D0 (en) Novel compounds
MY162146A (en) Pharmaceutical composition
CL2013000018A1 (es) Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros.
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
MX2016008448A (es) Conjugados de var2csa-farmaco.
EA201370018A1 (ru) Составы рифаксимина и их применение
MX348823B (es) Formulaciones estables de linaclotida.
PH12014501991B1 (en) Phenicol antibacterials
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
JO3154B1 (ar) عوامل مضادة لـ trpv4
MX2013013649A (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
PH12015501302A1 (en) Compositions comprising vortioxetine and donepezil
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
GB201302343D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods for using the same
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.